マクロビオティック (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "マクロビオティック" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

934^th place

57^th place

low place

low place

340^th place

871^st place

low place

low place

low place

low place

low place

low place

304^th place

20^th place

3,680^th place

low place

low place

low place

cancer.org

“Macrobiotic Diet”. American Cancer Society(アメリカがん協会) (2008年11月). 2012年10月閲覧。

ci-kyokai.jp

「日本CI協会70周年記念　第8回マクロビオティック医学シンポジウム特別対談マクロビオティックと新栄養学女子栄養大学副学長香川靖雄×日本CI協会会長勝又靖彦」『マクロビオティック』2015年10月、4-11頁。
「日本CI協会創立70周年記念第8回マクロビオティック医学シンポジウムレポートマクロビオティックと新栄養学」『マクロビオティック』2016年1月、4-9頁。
「東アジア米機能標準化会議マクロビオティックの食事と健康研究発表」『マクロビオティック』2015年3月。

doi.org

Harmon BE, Carter M, Hurley TG, Shivappa N, Teas J, Hébert JR (2015). “Nutrient Composition and Anti-inflammatory Potential of a Prescribed Macrobiotic Diet”. Nutr Cancer 67 (6): 933–40. doi:10.1080/01635581.2015.1055369. PMC 4596721. PMID 26212923.
Lerman RH (2010). “The macrobiotic diet in chronic disease”. Nutr Clin Pract 25 (6): 621–6. doi:10.1177/0884533610385704. PMID 21139126.
Villarini A, Pasanisi P, Traina A, et al. (2012). “Lifestyle and breast cancer recurrences: the DIANA-5 trial”. Tumori 98 (1): 1–18. doi:10.1700/1053.11494. PMID 22495696.
Papamichou, D.; Panagiotakos, D.B.; Itsiopoulos, C. (2019). “Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials”. Nutrition, Metabolism and Cardiovascular Diseases 29 (6): 531–543. doi:10.1016/j.numecd.2019.02.004. PMID 30952576.
Caccialanza R, Pedrazzoli P, Cereda E, et al. (2016). “Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)”. J Cancer 7 (2): 131–5. doi:10.7150/jca.13818. PMC 4716844. PMID 26819635.
Soare A, Khazrai YM, Del Toro R, et al. (2014). “The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial”. Nutr Metab (Lond) 11: 39. doi:10.1186/1743-7075-11-39. PMC 4190933. PMID 25302069.
Soare A, Del Toro R, Khazrai YM, et al. (2016). “A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes”. Nutr Diabetes 6 (8): e222. doi:10.1038/nutd.2016.29. PMC 5022142. PMID 27525817.
Soare A, Del Toro R, Roncella E, et al. (2015). “The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial”. BMJ Open Diabetes Res Care 3 (1): e000079. doi:10.1136/bmjdrc-2014-000079. PMC 4379741. PMID 25852946.
Fallucca F, Fontana L, Fallucca S, Pianesi M (2015). “Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes”. World J Diabetes 6 (3): 403–11. doi:10.4239/wjd.v6.i3.403. PMC 4398897. PMID 25897351.
Candela M, Biagi E, Soverini M, et al. (2016). “Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet”. Br. J. Nutr. 116 (1): 80–93. doi:10.1017/S0007114516001045. PMC 4894062. PMID 27151248.
Soare A, Khazrai YM, Fontana L, et al. (2017). “Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial”. Metab. Clin. Exp. 69: 148–156. doi:10.1016/j.metabol.2017.01.023. PMID 28285645.
“Zen Macrobiotic Diets”. JAMA: the Journal of the American Medical Association 218 (3): 397. (1971). doi:10.1001/jama.1971.03190160047009.

genpaku.org

『懐疑論者の事典下』　楽工社、2008年、ISBN 4903063135。The Skeptic's Dictionary, Wiley, 2003. 参考「マクロビオティックス macrobiotics」(The Skeptic's Dictionary日本語版、1999年10月20日)では、参考文献に1993年の文献が提示されている。

google.co.jp

books.google.co.jp

山田英知郎『健康と元気のためのマクロビオティックのすすめ』秀和システム、ISBN 978-4798014401
福山さき『ポケット図解マクロビオティック正食の心得健康読本』秀和システム、2007年、ISBN 978-4798015514
久司道夫『マクロビオティックをやさしくはじめる』成甲書房、2004年。ISBN 9784880861753。
久司道夫『マクロビオティックが幸福をつくる』成甲書房、2005年。ISBN 978-4880861784
久司道夫『マクロビオティックをやさしくはじめる』成甲書房、2004年。ISBN 9784880861753。32-33頁。

macrobian.net

半断食セミナーなどを主宰する橋本宙八が、1985年、日本において小冊子を創刊する際、自称ないし他称としてひろくマクロビオティック実践者を意味する用語として使用を始めた。マクロビアンの由来

nih.gov

pubmed.ncbi.nlm.nih.gov

Harmon BE, Carter M, Hurley TG, Shivappa N, Teas J, Hébert JR (2015). “Nutrient Composition and Anti-inflammatory Potential of a Prescribed Macrobiotic Diet”. Nutr Cancer 67 (6): 933–40. doi:10.1080/01635581.2015.1055369. PMC 4596721. PMID 26212923.
Lerman RH (2010). “The macrobiotic diet in chronic disease”. Nutr Clin Pract 25 (6): 621–6. doi:10.1177/0884533610385704. PMID 21139126.
Villarini A, Pasanisi P, Traina A, et al. (2012). “Lifestyle and breast cancer recurrences: the DIANA-5 trial”. Tumori 98 (1): 1–18. doi:10.1700/1053.11494. PMID 22495696.
Papamichou, D.; Panagiotakos, D.B.; Itsiopoulos, C. (2019). “Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials”. Nutrition, Metabolism and Cardiovascular Diseases 29 (6): 531–543. doi:10.1016/j.numecd.2019.02.004. PMID 30952576.
Caccialanza R, Pedrazzoli P, Cereda E, et al. (2016). “Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)”. J Cancer 7 (2): 131–5. doi:10.7150/jca.13818. PMC 4716844. PMID 26819635.
Soare A, Khazrai YM, Del Toro R, et al. (2014). “The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial”. Nutr Metab (Lond) 11: 39. doi:10.1186/1743-7075-11-39. PMC 4190933. PMID 25302069.
Soare A, Del Toro R, Khazrai YM, et al. (2016). “A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes”. Nutr Diabetes 6 (8): e222. doi:10.1038/nutd.2016.29. PMC 5022142. PMID 27525817.
Soare A, Del Toro R, Roncella E, et al. (2015). “The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial”. BMJ Open Diabetes Res Care 3 (1): e000079. doi:10.1136/bmjdrc-2014-000079. PMC 4379741. PMID 25852946.
Fallucca F, Fontana L, Fallucca S, Pianesi M (2015). “Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes”. World J Diabetes 6 (3): 403–11. doi:10.4239/wjd.v6.i3.403. PMC 4398897. PMID 25897351.
Candela M, Biagi E, Soverini M, et al. (2016). “Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet”. Br. J. Nutr. 116 (1): 80–93. doi:10.1017/S0007114516001045. PMC 4894062. PMID 27151248.
Soare A, Khazrai YM, Fontana L, et al. (2017). “Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial”. Metab. Clin. Exp. 69: 148–156. doi:10.1016/j.metabol.2017.01.023. PMID 28285645.

ncbi.nlm.nih.gov

Harmon BE, Carter M, Hurley TG, Shivappa N, Teas J, Hébert JR (2015). “Nutrient Composition and Anti-inflammatory Potential of a Prescribed Macrobiotic Diet”. Nutr Cancer 67 (6): 933–40. doi:10.1080/01635581.2015.1055369. PMC 4596721. PMID 26212923.
Caccialanza R, Pedrazzoli P, Cereda E, et al. (2016). “Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)”. J Cancer 7 (2): 131–5. doi:10.7150/jca.13818. PMC 4716844. PMID 26819635.
Soare A, Khazrai YM, Del Toro R, et al. (2014). “The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial”. Nutr Metab (Lond) 11: 39. doi:10.1186/1743-7075-11-39. PMC 4190933. PMID 25302069.
Soare A, Del Toro R, Khazrai YM, et al. (2016). “A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes”. Nutr Diabetes 6 (8): e222. doi:10.1038/nutd.2016.29. PMC 5022142. PMID 27525817.
Soare A, Del Toro R, Roncella E, et al. (2015). “The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial”. BMJ Open Diabetes Res Care 3 (1): e000079. doi:10.1136/bmjdrc-2014-000079. PMC 4379741. PMID 25852946.
Fallucca F, Fontana L, Fallucca S, Pianesi M (2015). “Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes”. World J Diabetes 6 (3): 403–11. doi:10.4239/wjd.v6.i3.403. PMC 4398897. PMID 25897351.
Candela M, Biagi E, Soverini M, et al. (2016). “Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet”. Br. J. Nutr. 116 (1): 80–93. doi:10.1017/S0007114516001045. PMC 4894062. PMID 27151248.

nii.ac.jp

kaken.nii.ac.jp

代表研究者香川靖雄ベジタリアンの脂肪酸不飽和化酵素遺伝子多型による脂質栄養の解析（科学研究費助成データベース）

si.edu

smithsonianlegacies.si.edu

Macrobiotic food, 1990s (Smithsonian Institution Press)

americanhistory.si.edu

Health Food: Macrobiotic Brown Rice National Museum of American History, Division Medicine and Science

university.jp

nodaiweb.university.jp

East Asia Conference on Standardization of Rice Function, Dec 10–12 2014.

wcrf.org

World Cancer Research Fund and American Institute for Cancer Research (2007). Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Amer. Inst. for Cancer Research. p. 196. ISBN 978-0972252225